255 related articles for article (PubMed ID: 7907042)
1. Synchronous dual primary ovarian and endometrial carcinomas.
Pearl ML; Johnston CM; Frank TS; Roberts JA
Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
[TBL] [Abstract][Full Text] [Related]
2. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
4. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
7. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
8. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
[TBL] [Abstract][Full Text] [Related]
11. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
[TBL] [Abstract][Full Text] [Related]
12. Simultaneously detected primary malignant tumors of ovary and endometrium with unusual histology.
Papathanasiou K; Tolikas A; Dovas D; Kostopoulou E; Fragkedakis N; Tzafettas J
Int J Gynecol Cancer; 2005; 15(6):1191-4. PubMed ID: 16343211
[TBL] [Abstract][Full Text] [Related]
13. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
[TBL] [Abstract][Full Text] [Related]
14. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis?
Kondi-Pafiti A; Grapsa D; Liapis A; Papadias K; Kairi-Vassilatou E; Hasiakos D
Eur J Gynaecol Oncol; 2008; 29(3):256-9. PubMed ID: 18592790
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
[TBL] [Abstract][Full Text] [Related]
16. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
[TBL] [Abstract][Full Text] [Related]
17. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
Soovares P; Pasanen A; Bützow R; Lassus H
Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
[TBL] [Abstract][Full Text] [Related]
18. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital.
Natee J; Kietpeerakool C; Srisomboon J; Khunamornpong S; Suprasert P; Phongnarisorn C; Cheewakriangkrai C; Charoenkwan K; Siriaree S; Pantusart A
Asian Pac J Cancer Prev; 2006; 7(2):234-8. PubMed ID: 16839215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
